- Home
- KTCC vs PYPD Comparison
KTCC vs PYPD Comparison
Compare KTCC & PYPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KTCC
- PYPD
- Stock Information
- Founded
- KTCC 1969
- PYPD 2008
- Country
- KTCC United States
- PYPD Israel
- Employees
- KTCC N/A
- PYPD N/A
- Industry
- KTCC Electrical Products
- PYPD Medical/Dental Instruments
- Sector
- KTCC Technology
- PYPD Health Care
- Exchange
- KTCC Nasdaq
- PYPD Nasdaq
- Market Cap
- KTCC 34.0M
- PYPD 30.1M
- IPO Year
- KTCC N/A
- PYPD 2020
- Fundamental
- Price
- KTCC $2.30
- PYPD $2.40
- Analyst Decision
- KTCC
- PYPD Strong Buy
- Analyst Count
- KTCC 0
- PYPD 2
- Target Price
- KTCC N/A
- PYPD $10.50
- AVG Volume (30 Days)
- KTCC 27.6K
- PYPD 10.7K
- Earning Date
- KTCC 05-06-2025
- PYPD 05-07-2025
- Dividend Yield
- KTCC N/A
- PYPD N/A
- EPS Growth
- KTCC N/A
- PYPD N/A
- EPS
- KTCC N/A
- PYPD N/A
- Revenue
- KTCC $514,394,000.00
- PYPD N/A
- Revenue This Year
- KTCC N/A
- PYPD N/A
- Revenue Next Year
- KTCC N/A
- PYPD N/A
- P/E Ratio
- KTCC N/A
- PYPD N/A
- Revenue Growth
- KTCC N/A
- PYPD N/A
- 52 Week Low
- KTCC $2.25
- PYPD $2.30
- 52 Week High
- KTCC $6.14
- PYPD $5.09
- Technical
- Relative Strength Index (RSI)
- KTCC 29.20
- PYPD 32.61
- Support Level
- KTCC $2.38
- PYPD $2.66
- Resistance Level
- KTCC $2.70
- PYPD $2.75
- Average True Range (ATR)
- KTCC 0.10
- PYPD 0.10
- MACD
- KTCC 0.01
- PYPD -0.03
- Stochastic Oscillator
- KTCC 8.33
- PYPD 14.62
About KTCC Key Tronic Corporation
Key Tronic Corp is an electronic manufacturing service provider. The company provides electronic manufacturing services to original equipment manufacturers in the United States and globally. Its primary services include integrated electronic and mechanical engineering, precision plastic molding, sheet metal fabrication, printed circuit board (PCB) and complete product assembly, component selection, sourcing and procurement, logistics, and new product testing and production. The firm derives a majority of its revenue from the United States.
About PYPD PolyPid Ltd.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.